2011 Congress

                                                                SPEAKER BIOS

                                          Bios - National Pharmaceutical Congress 2011

                                                               

                                                                PHOTO ALBUM                                                                                                                                                          Click here to see photos from the congress.

 

                                                             AGENDA

 
Le Congrès Pharmaceutique National 2011 
National Pharmaceutical Congress 2011 - Wednesday, March 30, 2011 Toscana Conference Centre, Vaughan, Ont. 
Conference Title: 11 STRATEGIES FOR A FASTER SMARTER PHARMA 

Registration, Continental Breakfast 6:45-8:00 


Session 1 8:00-9:00 

Moderator, David Renwick, Director, Pangaea Group 
Introduction: David Renwick, Session Chair and Conference Co-chair (touchpad questions) 8:00-8:05 

1. Russell Williams, President, Rx &D 8:05-8:15 
Presentation title: Key Issues that keep Rx&D members awake 
2. Peter Brenders, President & CEO, BIOTECanada 8:15-8:25 
Presentation title: Key Issues that keep BIOTECanada members awake 
3. Morris Goodman, Chairman of the Board, Pharmascience Inc. 8:25-8:35 
Presentation title: Key issues that keep the Canadian Generic Association members awake 
4. David Skinner, President, Consumer Health Products Canada 8:35-8:45 
Presentation title: Key issues that keep Consumer Health Product leaders awake 
Audience Interaction 8:45-9:00 

OXFORD DEBATE I 9:00-9:20 
Resolved: This house supports the establishment of the “National Center for Advancing Translational Sciences”, funded by the US Government, to speed the development of new drugs by conducting early-stage research that the pharmaceutical industry is unable or unwilling to perform. 
Moderator: Dr. Shafiq Qaadri, MPP 
Moderator: Touchpad Voting 
For the affirmative: Mark McElwain, kbs+p (Toronto) 5 mins. 
For the negative: Jill Donahue, Excellerate (Toronto) 5 mins 
Rebuttals (90 seconds each) 
Moderator: (2nd audience touchpad vote, and resolution) 
Audience Interaction 

Nutritional Break, Networking 9:20-9:40 

Session 2 9:40-10:35 
Moderator: Michael Brogan (IMS Brogan, Montreal) 9:40-9:45

1. Brian Jahns, Director of Hematology Business Unit, Hoffmann-La Roche Limited 9:45-9:55 
Presentation title: It's Not an Option: Customer Centricity is the Future 
2. Andreas Seiger, Marketing Director, Diabetes Care - Novo Nordisk Canada Inc. 9:55-10:00
Presentation title: Lifecycle Management & Forecasting 
3. Doug Grant, Head, Corporate Affairs, Bayer Healthcare 10:00-10:10 
Presentation title: The Challenge of Reimbursement 
4. Kevin Leshuk, General Manager, Celgene Inc. 10:10-10:20 
Presentation title: The Tantalus Paradigm 
Audience Interaction 10:20-10:25 

OXFORD DEBATE II 10:25-10:45 
Resolved: This house believes corporate intellectual property rights and worldwide human health initiatives must always be mutually exclusive concepts 
Introduction: 3 mins. 
Moderator, Dr. Shafiq Qaadri, MPP Touchpad Voting 
For the affirmative: Eileen McMahon, Torys (Toronto) 5 mins 
For the negative: Marc Lalande, Learning Andrago Inc. (Montreal) 
Rebuttals (90 seconds each) 
Moderator: (2nd audience touchpad vote, and resolution) 
Audience Interaction 

Session 3 10:45-11:45 
Introduction: Mitchell Shannon, Chronicle Companies, Session Chair and Conference Co-chair (touchpad questions) 10:45-10:50 

1. Pat Forsythe, Neurosciences Business Unit Director, Allergan Inc. 10:50-11:00 
Presentation title: Selling Science: Marketing Specialty Care Products 
2. Robin Hunter, Vice President, Critical Care, Leo Pharma Inc. 11:00-11:10 
Presentation title: Five Tips for a Better, Smarter Pharma 
3.Thomas Schlader, General Manager, Valeant Canada Ltd. 11:10-11:20 
Presentation title: 11 Strategies to become a faster/smarter pharma- "the Valeant experience". 
4.Claude Perron, Vice President & General Manager, Shire Canada Inc. 11:20-11:30 
Presentation title: The key learnings of the Adderall XR® suspension and re-instatement of NOC in 2005 
5. Michael Tremblay, President, Astellas Pharma Canada Inc. 11:30-11:40 
Presentation title: Improving Patient Lives Program 
Audience Interaction 11:40-11:45 

Concluding remarks and conference summary: 11:45-11:50 


Champagne reception to honor the 2011 inductees to the Canadian Healthcare Marketing Hall of Fame 11:50:12:30 


CANADIAN HEALTHCARE MARKETING HALL OF FAME GALA LUNCHEON AND INDUCTION CEREMONIES12:30-2:15
 

 

Contact Us

Chronicle Companies

555 Burnhamthorpe Road,

Suite 306

Toronto, ON                           M9C 2Y3

Phone: 416-916-2476

Email:health@chronicle.org

Website:www.chronicle.ca

Or use our contact form.

Latest Industry News

Stay Connected!

Print Print | Sitemap
Reinventing the Pharma Industry